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The Authors Reply: Davis and Cooper note that the Minnesota donor cohort is almost entirely white, whereas in the United States as a whole, 86% of donors are white. 1 They also comment on the ideal control group for kidney donors. As we note in our discussion, the ideal group would have been persons who were deemed suitable for donation but who did not donate. We compared the rate of incident ESRD among our donors with the rate among whites in the United States; most of our donors (>60%) are residents of Minnesota. In 2006, the rate of incident ESRD in Minnesota was almost identical to that in the rest of the country (359.8 and 363.2 cases per million, respectively). In previous years, the rate was 20 to 40 cases per million lower in Minnesota than in the rest of the country. 2 We hope that the Renal and Lung Donors Evaluation (RELIVE) study (ClinicalTrials. gov number, NCT00608283), which will report on more than 8000 kidney donors, with better minority representation and more comparable controls, will address some of these concerns.
Freeman points out the critical finding that some donors had hypertension that was poorly controlled or undiagnosed. We strongly agree that there is a need to aggressively monitor and treat blood-pressure elevations in all kidney donors.
Ross and Thistlethwaite note that 3 of the 11 donors in whom ESRD developed were nonwhite. One was a black woman, one an Asian woman, and one a Native American man. The Asian donor had hypertension-related ESRD; the cause was unknown in the case of the other two. There were 93 black donors, 39 Asian donors, and 76 NativeAmerican donors, yielding an incidence of ESRD of 1.1%, 2.6%, and 1.3%, respectively. Although the numbers are too small to draw conclusions, these data clearly indicate that race or ethnic background should be considered in the overall assessment of risk, an area that our study could not fully address. Dols et al. note that there was no age-related decline in GFR in their longitudinal studies of GFR in donors. We have measured GFR longitudinally in 38 of our donors and noted a decline of 0.59±3.84 ml per minute per year, a rate that is similar to that observed in our cross-sectional measurement of GFR. At the second GFR measurement, GFR had decreased in 24 donors, had stayed the same in 2, and had actually risen in 12, suggesting that a GFR decline with aging may not be universal. 
A Surgical Safety Checklist
To the Editor: Haynes et al. (Jan. 29 issue) 1 report on a surgical safety checklist to reduce morbidity and mortality in a global population. Transferring the concept of checklists from aviation to surgery sounds intuitively sensible. However, to claim that the use of checklists can reduce the perioperative rate of death by more than 30%, based on extrapolation across a mixture of hospitals in developed and developing countries, may be misleading and counterproductive. In any case, all except one of the participating hospitals in developed countries had a preintervention rate of death that exceeded the published normal range of 0.4% to 0.8%. Indeed, the rate of death in the only hospital at the extreme end of the normal range increased from 0.8% to 1.4% after the intervention.
In the United Kingdom, the National Patient Safety Agency has responded rapidly to this study by issuing a safety alert to all National Health Service hospitals; this alert requires the hospitals to use a modified 26-point checklist by 2010. 2 Although we support this initiative because it is likely to promote greater team cooperation, we are concerned that the implied reduction in the perioperative rate of death is unlikely to be realized in the United Kingdom, and ultimately, this may adversely affect credibility and compliance with this potentially valuable adjunct to safety measures for surgical patients. To the Editor: Haynes and colleagues show the benefit of the surgical safety checklist for improving perioperative care. Although the authors state that the intervention was neither "costly nor lengthy," information to support this statement was not presented. The length of the checklist must be considered, especially for the anesthetized patient who is prone to physiological disturbance, including hypothermia. Thus, it is unclear why a "time out" should be conducted after the induction of anesthesia, rather than immediately before the induction of anesthesia (this is particularly important in lower-income environments with less availability of physiological support). The significant benefits of education, checklist awareness, and increased resource utilization must be realized. The Authors Reply: Martin et al. express concern that the rates of death in our study were not "normal" and that the beneficial results observed may therefore not be generalizable. We well recognize that an eight-hospital study cannot provide a precise estimate of the magnitude of reduction in harm that is possible from broad implementation of the checklist. However, the larger criticism is flawed. The rates of death that we reported were for procedures conducted in the study operating rooms, not for hospital-wide procedures; the case mix varied widely among hospitals, and the hospitals themselves had enormous diversity. In addition, the normal rate of postoperative death is unknown for the mix of cases observed in this international group of hospitals; a comparison with data from limited studies in developed countries would be invalid. Sanders and Jameson correctly point out that the cost and time involved in such an intervention are important considerations. The checklist was designed to be brief; in testing, we aimed for a total duration of less than 2 minutes in routine situations, as shown in a training video provided to the study sites. 1 The "time out" occurs after induction of anesthesia because it is not always practical to have the surgeon present before induction. In addition, errors may be introduced in the period between the induction of anesthesia and skin incision, including incorrect draping and delay of antibiotic administration. The cost of providing pulse oximetry and prophylactic antibiotics is an important concern. However, the WHO recommends that these resources be used as minimum standards for safe surgery and that the value of elective surgery in their absence be critically examined. 2 In clinical settings without oximetry, as many as 1 in 150 patients has been reported to have died from anesthesia-related causes, 3 and a surgical infection rate of more than 20% has been reported in settings without appropriate prophylactic antibiotics. 4 McCambridge et al. are legitimately concerned about the role observation may have played in the results. The precise cause-and-effect relationship between the checklist program and the observed reduction in complications is unclear. Observation could have produced a Hawthorne effect by three possible mechanisms. First, the presence of an observer may have affected outcomes, but, as noted, we found no such effect. Second, teams may have used the checklist more assiduously because of the ongoing study, but this would not weaken any checklist effect. Finally, there is the possibility that the performance of the operative teams improved because of their awareness of being studied. However, we would recommend that any attempt to implement the checklist include monitoring of basic surgical outcomes, resulting in a similar scrutiny of results.
Levin astutely points out that lessons from aviation can be applied to improve safety in health care. The design of the WHO checklist was in- 
